Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4508236 | 0.88 | FFAR1 (0.32) | FFAR1FFAR4 | |
| SCHEMBL4504892 | 0.85 | FFAR1 (0.33) | FFAR1FFAR4 | |
| SCHEMBL4519235 | 0.83 | FFAR1 (0.41) | FFAR1FFAR4 | |
| SCHEMBL4504784 | 0.77 | ACACB (0.47) | FFAR1FFAR4 | |
| SCHEMBL13606699 | 0.74 | FFAR1 (0.33) | FFAR1FFAR4 | |
| SCHEMBL13613952 | 0.73 | GLRA3 (0.34) | — | |
| SCHEMBL4516332 | 0.72 | FFAR1 (0.49) | FFAR1FFAR4 | |
| SCHEMBL13606700 | 0.71 | FFAR1 (0.41) | FFAR1FFAR4 | |
| SCHEMBL4504895 | 0.70 | ACACB (0.34) | — | |
| SCHEMBL13613844 | 0.70 | CD274 (0.38) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1696899-A1 | METHODS FOR TREATING RETINOID RESPONSIVE DISORDERS USING SELECTIVE INHIBITORS OF CYP26A AND CYP26B | ALLERGAN, INC. (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005058301-A1 | METHODS FOR TREATING RETINOID RESPONSIVE DISORDERS USING SELECTIVE INHIBITORS OF CYP26A AND CYP26B | ALLERGAN, INC. (US) | 2005-06-30 | — | — | WO | disclosed |